Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | S-1/A |
Revenues: |
United States | 70.0 | 50.4 | 36.8 | 26.7 |
International | 41.9 | 29.6 | 21.7 | 16.1 |
Total revenues | 111.9 | 79.9 | 58.5 | 42.8 |
Revenue growth [+] | 40.0% | 36.7% | 36.7% | |
United States | 38.9% | 37.0% | 37.6% | |
International | 41.8% | 36.1% | 35.2% | |
Cost of goods sold | 29.5 | 21.6 | 19.0 | 15.2 |
Gross profit | 82.4 | 58.3 | 39.5 | 27.6 |
Gross margin | 73.6% | 73.0% | 67.6% | 64.5% |
Selling, general and administrative [+] | 58.3 | 40.7 | 26.2 | 24.8 |
Sales and marketing | 28.2 | 21.8 | 13.7 | 15.3 |
General and administrative | 30.1 | 18.9 | 12.5 | 9.6 |
Research and development | 29.6 | 21.2 | 19.0 | 15.3 |
EBITDA [+] | 3.9 | 3.3 | -0.1 | -9.6 |
EBITDA growth | 15.9% | -2537.2% | -98.6% | |
EBITDA margin | 3.5% | 4.2% | -0.2% | -22.5% |
Depreciation and amortization | 9.4 | 6.9 | 5.5 | 2.9 |
EBIT [+] | -5.5 | -3.6 | -5.7 | -12.5 |
EBIT growth | 55.2% | -36.8% | -54.8% | |
EBIT margin | -5.0% | -4.5% | -9.7% | -29.2% |
Non-recurring items [+] | 0.0 | 0.0 | 0.0 | 0.1 |
Loss (gain) on sale of assets | 0.0 | 0.0 | 0.0 | 0.1 |
Interest expense | 0.2 | 0.2 | 0.2 | 0.3 |
Interest expense | 0.2 | 0.2 | 0.2 | 0.3 |
Other income (expense), net [+] | -0.5 | -0.1 | 0.0 | -0.1 |
Other | | | | 0.4 |
Pre-tax income | -6.3 | -3.9 | -5.9 | -13.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -6.3 | -3.9 | -5.9 | -13.0 |
Net margin | -5.6% | -4.9% | -10.0% | -30.3% |
|
Basic EPS [+] | ($0.74) | ($0.52) | ($0.83) | ($2.50) |
Growth | 41.6% | -37.1% | -66.9% | |
Diluted EPS [+] | ($0.74) | ($0.52) | ($0.83) | ($2.50) |
Growth | 41.6% | -37.1% | -66.9% | |
|
Shares outstanding (basic) [+] | 8.5 | 7.5 | 7.1 | 5.2 |
Growth | 13.0% | 6.1% | 36.5% | |
Shares outstanding (diluted) [+] | 8.5 | 7.5 | 7.1 | 5.2 |
Growth | 13.0% | 6.1% | 36.5% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|